Search - tctmd.com

Displaying 501 - 520 of 747

Sort: Relevancy | Date

Presentation TCT 2012

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from OCT

Presenter: Evelyn Regar

October 25, 2012

Presentation TCT 2012

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from Grayscale and VH-IVUS

Presenter: Akiko Maehara

October 25, 2012

Presentation TCT 2012

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from NIRS

Presenter: James Goldstein

October 25, 2012

Presentation TCT 2012

IVUS-Guided PCI: From Stent Sizing to Predicting Thrombosis and Restenosis

Presenter: Gary Mintz

October 25, 2012

Presentation TCT 2012

IVUS Assessment of Stent Thrombosis and Restenosis

Presenter: Soo-Jin Kang

October 25, 2012

Presentation TCT 2012

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Presenter: Suhas Lele

October 25, 2012

News Conference News TCT 2012

Positive Results Seen with Angioplasty for Critical Hand Ischemia

October 25, 2012

News Conference News TCT 2012

Paclitaxel-Eluting Balloon Results in High Patency Rate at 1 Year in Below-the-Knee Lesions

October 25, 2012

Presentation TCT 2012

Evaluation and Treatment of In-Stent Restenosis

Presenter: Christoph Kaiser

October 25, 2012

News Industry News

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

October 25, 2012

Presentation TCT 2012

Management of Diffuse Restenosis After DES

Presenter: Alaide Chieffo

October 24, 2012

Presentation TCT 2012

Case 2: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Presenter: Ricardo Costa

October 24, 2012

News Industry News

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

October 24, 2012

News Conference News TCT 2012

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

October 24, 2012

News Industry News

Nitinol Stent Performs Better Than Balloon Angioplasty Alone in Treating Lesions of the Popliteal Artery

October 24, 2012

News Conference News TCT 2012

ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD

October 24, 2012

News Conference News TCT 2012

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

October 24, 2012

News Conference News TCT 2012

DEBATE-SFA Favors Predilatation with Drug-Eluting Balloon Before BMS

October 24, 2012

News Conference News TCT 2012

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

October 23, 2012

Presentation TCT 2012

In-Stent Restenosis: Mechanisms, Predictors, and Treatment

Presenter: Roxana Mehran

October 23, 2012

Advertisement

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from OCT

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from Grayscale and VH-IVUS

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from NIRS

IVUS-Guided PCI: From Stent Sizing to Predicting Thrombosis and Restenosis

IVUS Assessment of Stent Thrombosis and Restenosis

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Positive Results Seen with Angioplasty for Critical Hand Ischemia

Paclitaxel-Eluting Balloon Results in High Patency Rate at 1 Year in Below-the-Knee Lesions

Evaluation and Treatment of In-Stent Restenosis

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

Management of Diffuse Restenosis After DES

Case 2: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

Nitinol Stent Performs Better Than Balloon Angioplasty Alone in Treating Lesions of the Popliteal Artery

ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

DEBATE-SFA Favors Predilatation with Drug-Eluting Balloon Before BMS

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

In-Stent Restenosis: Mechanisms, Predictors, and Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content